Has antifungal susceptibility testing come of age

Cited by (361)

Items 301–361 of 361

1. Candida in HIV Infection
   Emma J. Devitt, William G. Powderly · 2008 · Elsevier eBooks
2. Fungal Drug Resistance Assays
   Sevtap Arıkan-Akdağlı, John H. Rex · 2017 · Springer eBooks
3. The Correlation between Median Rhomboid Glossitis and Fungal Infection: A Review Article
   Nanda Rachmad Putra Gofur · 2020 · Biomedical Journal of Scientific & Technical Research
4. Impact de la consommation d'antifongiques sur Candida sp. : étude dans un service de réanimation médicale de 2004 à 2009 au CHU de Grenoble
   Pierre‐Edouard Fournier · 2011 · HAL
5. Resistance to Antifungal Agents
   Sevtap Arıkan, John H. Rex · 2010 · Wiley eBooks
6. Introduction
   Marina Sokóvić, Κωνσταντίνος Λιάρας · 2020 · Elsevier eBooks
7. Can Prolonged Incubation of Negative Blood Cultures Show Fungal Positivity?
   Ali Korhan Sığ, Diğdem Özer Yıldırım, Başak Göl Serin, Mustafa Güney · 2023 · Balıkesır Health Sciences Journal
8. Diyabetik Bir Hastada Görülen İlk Candida parapsilosis Epididimoorşiti
   Esmeray Mutlu Yılmaz, Melek Bilgin, Turgut SERDAŞ · 2024 · Flora the Journal of Infectious Diseases and Clinical Microbiology
9. Current Controversies in the Treatment of Fungal Infections
   Christopher D. Pfeiffer, John R. Perfect, Barbara Dudley Alexander · 2011 · Humana Press eBooks
10. Yeasts
    Sean X. Zhang, Nathan P. Wiederhold · 2016 · Microbiology Spectrum
11. Care of the Child with an Infectious Disease or Immunological Defect
    Ashley N. Gyura, Emily R. Harrison · 2022 · Springer eBooks
12. Antifungal Agents
    Russell Edward Lewis, Annette W. Fothergill · 2015 · Springer eBooks
13. Antifungal susceptibility testing, reporting and antifungal resistance: current status
    Ali Korhan Sığ · 2023 · Turkish Bulletin of Hygiene and Experimental Biology
14. Management of Resistant Candida Infections
    Sanya Clements, Christopher C. Kibbler · 2004 · Humana Press eBooks
15. Patents on antifungal compounds effective against Candida species: 1999 ? 2002
    Constantine G. Haidaris · 2003 · Expert Opinion on Therapeutic Patents
16. CLINICAL IMPACT OF THE FUNGICIDAL ACTIVITY OF CASPOFUNGIN ADMINISTERED ALONE OR IN COMBINATION IN CRITICALLY ILL PATIENTS WITH SEVERE ABDOMINAL CANDIDIASIS REFRACTORY TO CONVENTIONAL ANTIFUNGAL DRUGS: CASE STUDIES AND CRITICAL REVIEW OF THE PROBLEM
    Jean-Luc Canivet · 2004 · Acta Clinica Belgica
17. UTILIDAD CLÍNICA DE LAS PRUEBAS DE SUSCEPTIBILIDAD ANTIMICÓTICA
    Pilar Cebollero Rivas, Ruth Quevedo Serrano · 2003
18. UNIVERSIDADE FEDERAL DO CEARÁ FACULDADE DE MEDICINA PRÓ-REITORIA DE PESQUISA E PÓS-GRADUAÇÃO PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS MÉDICAS
    Maria Auxiliadora Bezerra Fechine · 2011
19. Aspergillosis
    Catherine W. Kohn · 2007 · Elsevier eBooks
20. The Development of Photo-activated Antimicrobial Dyes Against Opportunistic Infections
    Murhaf Jalab · 2020 · CLOK (University of Central Lancashire)
21. Antifungal Chemotherapy
    Keith E. Baptiste · 2024
22. Susceptibility Test Methods: Yeasts and Filamentous Fungi
    Elizabeth M. Johnson, Maiken Cavling Arendrup · 2023 · ClinMicroNow
23. Susceptibility Test Methods: Yeasts and Filamentous Fungi
    Elizabeth M. Johnson, Maiken Cavling Arendrup · 2023 · ClinMicroNow
24. Antifungal Susceptibility Tests
    Errol Reiss, H. Jean Shadomy, G. Marshall Lyon · 2011
25. Antifungal Drug Resistance: Clinical Importance, in vitro Detection and Implications for Prophylaxis and Treatment
    Beth A. Arthington, João Pedro Frade · 2010 · Issues in infectious diseases
26. Current Strategies in the Treatment of Fungal Infections in the Intensive Care Unit Setting
    Mitchell Goldman, George A. Sarosi · 2009 · Wiley eBooks
27. Management of Infection With Naturally Amphotericin B-Resistant Fungi
    Thean Yen Tan, Rosemary A. Barnes · 2004 · Humana Press eBooks
28. Avaliação da formação de biofilme de fungos emergentes e sua susceptibilidade a antifúngicos na forma livre e nanoencapsulada
    Roberta Stefanello de Jesus · 2013 · Americanae (AECID Library)
29. The Impact of Qualitative Respiratory Cultures on Mortality in Critically III Patients with Hospital-Acquired Pneumonia
    Sarah R. Peppard, Marc H. Scheetz, Michael J. Postelnick, Kristin M. Darin · 2010 · Hospital Pharmacy
30. Current concepts in antifungal susceptibility testing, Part II
    Robert S. Liao, W. Michael Dunne · 2003 · Clinical Microbiology Newsletter
31. Profili di sensibilità agli agenti antifungini di lieviti e miceti lievito-simili isolati negli ospedali torinesi
    Viviana Cristina Tullio, Janira Roana, Narcisa Mandras, Giuliana Banche, Valeria Allizond, Ornella Cervetti, Michele Panzone, Cristina Crocillà, Ester Gaido, Barbara Fianchino et al. · 2005 · Microbiologia medica
32. Estudo retrospectivo de dez anos de candidemia em hospital terciário de Campo Grande-MS, Brasil
    Lucas Xavier Bonfietti, Márcia de Souza Carvalho Melhem · 2011 · BEPA Boletim Epidemiológico Paulista
33. CARACTERIZAÇÃO DE FUNGOS ENVOLVIDOS EM INFECÇÕES NOSOCOMIAIS
    Xisto Sena Passos · 2007 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
34. Perspectives on antifungal susceptibility testing in Candida
    Sachin Chandrakant Deorukhkar, S Saini, Stephen K. Mathew · 2014 · International Journal of Infectious and Tropical Diseases
35. Antifongigramme et concentration minimale inhibitrice
    V. Letscher‐Bru · 2011 · EMC - Biologie Médicale
36. What Every Steward Should Know About Pharmacokinetics and Pharmacodynamics
    Jason M. Pogue, Marc H. Scheetz · 2018 · Cambridge University Press eBooks
37. Applied Antifungal Pharmacometrics: Fluconazole and Echinocandins in the Treatment of Candidemia and Invasive Candidiasis
    Cornelius Joseph Clancy · 2014 · AAPS advances in the pharmaceutical sciences series
38. Laboratory Diagnosis of Fungal Diseases
    Barbara A. Byrne · 2007 · Elsevier eBooks
39. Faculty Opinions recommendation of Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program.
    Ana Victoria Espinel-Ingroff · 2008 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
40. Flucytosine
    Richard H. Drew · 2009 · CRC Press eBooks
41. Yeasts
    Sean X. Zhang, Nathan P. Wiederhold · 2016 · ASM Press eBooks
42. Characterisation of the cell wall protein Pga29p in the human pathogenic fungus Candida albicans
    Albert D. de Boer · 2009
43. Profils de résistance des germes responsables d’infections urinaires fébriles de l’enfant et protocoles d’antibiothérapie probabiliste. Une étude épidémiologique au CHRU de Strasbourg et CH de Saverne sur 2019–2020
    Mathilde Arabska, Marie‐Laure Girardin, Laurence Long, Antoine Grillon, Ariane Zaloszyc · 2022 · Néphrologie & Thérapeutique
44. Authors' reply
    Soniya Mahajan, ShyamS Pandey · 2017 · Indian Journal of Dermatology Venereology and Leprology
45. Pharmacokinetic–Pharmacodynamic Basis of Optimal Antibiotic Therapy
    Michael Noel Neely, Michael D. Reed · 2008 · Elsevier eBooks
46. Faculty Opinions recommendation of Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.
    Shahzad Mian, Christopher Hood · 2013 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
47. Antifungal Agents
    George R. Thompson, Thomas F. Patterson · 2014 · Springer eBooks
48. Antifungal Resistances
    Raquel Sabino · 2017 · Springer eBooks
49. Pharmacokinetic and Pharmacodynamic Basis of Optimal Antimicrobial Therapy
    Michael Noel Neely, Jason B. Sauberan, John S. Bradley · 2022 · Elsevier eBooks
50. TBHEB 2023-1 Vol 80 Full Printed Journal
    Utku ERCÖMERT · 2023 · Turkish Bulletin of Hygiene and Experimental Biology
51. Ten Clinical Pearls in Microbiology: How Effective Collaboration Optimizes Patient Care
    John C. Lam, Samuel Bourassa‐Blanchette · 2024 · The American Journal of Medicine
52. Refractory fungal infection: Three case reports highlighting good practice
    Rosemary A. Barnes, David Enoch, Wendy A Ingram, Jessica Martin, JENNIFER C. CLAY, Netta Tyler, Philip Lewis White · 2024 · Medical Mycology Case Reports
53. Antifungal Susceptibility Testing
    Nathan P. Wiederhold, Shawn R. Lockhart · 2023 · ClinMicroNow
54. Emergence of resistant tinea corporis in a low socioeconomic setting
    H Thabrew, Nayani P. Madarasinghe, Surammika Eriyagama, Shreenika De Silva Weliange, D. Reinel, Primali Irosha Jayasekera · 2025 · Clinical and Experimental Dermatology
55. Phenotypic and molecular antifungal susceptibility testing of yeast isolates from Pretoria
    Maren Hnaya · 2014 · UpSpace Institutional Repository (University of Pretoria)
56. Rapid Bacterial Identification through Biophysical Surface Topography Features
    Adam Krueger, Bikash Bogati, Raymond Copeland, Maryam Bidgoli, Jin Zhu, David S. Weiss, Peter J. Yunker · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
57. Epidémiologie et mécanismes de résistance d'Aspergillus fumigatus aux antifongiques triazolés : focus sur les patients atteints de mucoviscidose
    Rose‐Anne Lavergne · 2018
58. Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques
    Hanane Yousfi · 2019
59. Map is not territory: building useful antimicrobial resistance models
    Evan Pierce Brenner, Charmie K. Vang, Abhirupa Ghosh, Janani Ravi · 2026 · Trends in Microbiology
60. Efficacy of Cyanoacrylate Tissue Adhesive in Management of Multidrug-Resistant Fusarium Keratitis: A Case Report
    Cezmi Doğan, Fatma Burcu Ozdemir, Oğuzhan Kılıçarslan, Zeynep Yazgan, Gökhan Aygün · 2026 · Eye & Contact Lens Science & Clinical Practice
61. Tailored Treatment of Recalcitrant Tinea Cruris and Tinea Corporis: Insights from Antifungal Susceptibility Testing
    Azin Ayatollahi, Ensieh Lotfali, Fatemeh Amirinia, Mahsa Fattahi · 2026 · Research Square